Skip to main content

Table 1 Clinical characteristics and age distribution of study samples (serum samples) used for E2F5 and CA125 expression studies.

From: E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer

  Number of cases Age Cancer subtypes
    Serous
carcinoma
Mucinous
carcinoma
Endometroid
carcinoma
Clear cell
carcinoma
Others*
Normal 56 45.00 ± 15.00      
Benign 40 42.80 ± 16.65 5 11 14 0 10
Stage I/II 16 50.94 ± 12.16 2 4 6 3 1
Stage III/IV 32 52.32 ± 10.11 19 1 9 3 0